Joseph T. Morrissey Jr. - Feb 28, 2023 Form 4 Insider Report for Organon & Co. (OGN)

Role: Head of Manufacturing
Signature: /s/ Tarnetta V. Jones, as Attorney-in-Fact for Joseph T. Morrissey, Jr.
Stock symbol: OGN
Transactions as of: Feb 28, 2023
Transactions value $: -$47,194
Form type: 4
Date filed: 3/2/2023, 04:32 PM
Previous filing: May 5, 2022
Next filing: Apr 4, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	OGN	Common Stock	Options Exercise		+6.27K	+60.75%		16.6K	Feb 28, 2023	Direct	F1
transaction	OGN	Common Stock	Tax liability	-$47.2K	-1.88K	-11.34%	$25.09	14.7K	Feb 28, 2023	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	OGN	Restricted Stock Units	Options Exercise	$0	-6.27K	-100%	$0.00^*	0	Feb 28, 2023	Common Stock	6.27K		Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each Restricted Stock Unit converts into one share of Organon & Co. common stock.
F2	As originally reported on the Form 4, dated June 4, 2021, these Restricted Stock Units vested on December 31, 2022. These Restricted Stock Units were subsequently distributed to the Reporting Person on February 28, 2023.